The GLP-1 Craze
$99.00
GLP-1 medications like Ozempic are reshaping consumer behavior and sparking a surge in demand for high-fiber, protein-rich, and gut-health-focused foods – even among those not taking the drugs.
As accessibility to GLP-1 medications rises, food businesses that proactively adapt their product portfolios and supply chains will be best positioned to thrive. This month’s Food Institute monthly report offers insightful advice.
Topics in the report include a look at:
- The rise of GLP-1 agonists
- Shifting consumer behaviors
- The CPG market response
- The retail market potential
- The foodservice market potential
This individual report is $99 but is included for E-members, Professional Members or Corporate members.
To receive The Food Institute’s monthly reports and numerous other benefits, become an E-Member, Professional Member, or secure a Corporate License by visiting foodinstitute.com/joinfi/ now.
